Get started
Author

Natsuko Kameyama

Observed names: Natsuko KAMEYAMA, 菜つ子 亀山
ORCID: 0009-0008-9815-1910
Observed ORCID: 0009-0008-9815-1910
OpenAlex ID: A5081964162
Induction of a T-Helper 1 (Th1) Immune Response in Mice by an Extract from the Pleurotus eryngii (Eringi) Mushroom
2012 · Kazunori Ike, Natsuko Kameyama, et al. · Journal of Medicinal Food · 12
Gender differences in tail-skin flushing induced by nitrates and phosphodiesterase type 5 inhibitors in a climacteric mouse model
2009 · Hitomi Sejima, Koji Tominaga, et al. · European Journal of Pharmacology · 6
Current situation and issues regarding termination of risk management plans in Japan
2024 · Natsuko Kameyama, Aoi Hosaka, et al. · Frontiers in Medicine · 5
Important potential risks not reflected in Japanese drug labeling: implications for risk management plan termination
2026 · Natsuko Kameyama, Ayana Ide, et al. · DARU Journal of Pharmaceutical Sciences · 1
PDF
Important missing information in Japan's risk management plans: a cross-sectional analysis after a decade of implementation
2026 · Natsuko Kameyama, Ayana Ide, et al. · Frontiers in Medicine
PDF
Correction: Current situation and issues regarding termination of risk management plans in Japan
2026 · Natsuko Kameyama, Aoi Hosaka, et al. · Frontiers in Medicine
PDF
P-04 医薬品リスク管理計画における不足情報としてのSpecial Populationsの現状と課題
2025 · 菜つ子 亀山, 彩奈 井出, et al. · Japanese Journal of Pharmacoepidemiology/Yakuzai ekigaku
PDF
Has risk management plan system influenced the speed of package insert revisions in Japan?
2024 · Natsuko Kameyama, Aoi Hosaka, et al. · Frontiers in Medicine
PDF
Recommendations for Conducting Post-Marketing Database Study in Japan Based on the Critical Appraisal of Published Articles from Overseas Real-World Data (RWD) Analyses
2021 · Shinichi MATSUDA, Nobuyuki FUKADA, et al. · Japanese Journal of Pharmacoepidemiology/Yakuzai ekigaku
PDF
Works count: 9
Citation count: 24
H-index: 3
I10-index: 1
Year
Topic
Type